Results 131 to 140 of about 40,048 (221)

High In Vitro Activity of the Novel Pleuromutilin Antibiotic, Lefamulin, on Clinical <i>Helicobacter pylori</i> Isolates. [PDF]

Antibiotics (Basel)
Boyanova L, Boyanova LY, Kamburov V, Kandilarov N, Katsarov N, Gergova R, Boyanov VS, Markovska R.   +7 more
europepmc   +1 more source

Evidence-Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised Edition. [PDF]

Helicobacter
Bang CS, Kang SJ, Lim H, Kim SH, Lee MW, Nam SY, Tae CH, Kim SE, Kim SY, Jung HK, Kim BJ, Choi M, Jung HY, Kim BW, Korean College of Helicobacter and Upper Gastrointestinal Research.   +14 more
europepmc   +2 more sources

Local Price and Clarithromycin Resistance Shape the Cost of Vonoprazan Triple Therapy for Helicobacter pylori Eradication. [PDF]

Helicobacter
Zavos C.
europepmc   +1 more source

Eradication of Helicobacter pylori With Vonoprazan-Amoxicillin Dual Therapy as an Alternative for Bismuth-Based Quadruple Therapy: A Systematic Review and Noninferiority Meta-Analysis. [PDF]

J Gastroenterol Hepatol
Passos PRC, Filho VOC, Noronha MM, Maia MCB, Cançado GGL.   +4 more
europepmc   +1 more source

Prevalence of primary <i>Helicobacter pylori</i> antibiotic resistance in Europe over the past four decades. [PDF]

Gut Microbes
Nafria B, Nyssen OP, Narbaiza J, Montes M, Parra P, Gisbert JP, Bujanda L.   +6 more
europepmc   +1 more source

REAL-WORLD EFFECTIVENESS OF HIGH-DOSE DUAL THERAPY VS OPTIMIZED CLARITHROMYCIN TRIPLE THERAPY FOR HELICOBACTER PYLORI: A PROSPECTIVE COHORT STUDY WITH TEST-OF-CURE SENSITIVITY ANALYSES. [PDF]

Arq Gastroenterol
Ugarte Lastra A, Advincula Solis DE, Ramos Mamani H, Cedrón Cheng HG, Bellido-Caparo Á, Montezuma Calvo D, Vesco Monteagudo E, Poppele Molina G, Chirinos Vega JA, Espinoza-Ríos J, Frías-Ordoñez JS, Aguilar Sánchez V, Pinto Valdivia JL, Huerta Mercado Tenorio J.   +13 more
europepmc   +1 more source

A rare rosuvastatin-clarithromycin interaction presenting with acute liver injury and delayed rhabdomyolysis. [PDF]

Indian J Pharmacol
Prasad NT.
europepmc   +1 more source

Antimicrobial Resistance Profile of Helicobacter pylori in Shenzhen, China: A Retrospective Study From 2021 to 2024. [PDF]

Helicobacter
Wu F, Chen Y, Yang C.
europepmc   +1 more source

Longitudinal Antimicrobial Susceptibility Shifts in Environmental <i>Legionella pneumophila</i> from a Drinking Water Distribution System. [PDF]

Pathogens
Madagi L, Azrad M, Karp M, Peretz A, Sharaby Y.   +4 more
europepmc   +1 more source

Potassium-Competitive Acid Blockers for First-Line <i>Helicobacter pylori</i> Eradication: A Systematic Review and Meta-Analysis. [PDF]

Gastro Hep Adv
Kovarbasic CA, El Khiati C, Knölker HC, Benlloch S, Barrasa A.   +4 more
europepmc   +1 more source